Randomised double-blind placebo-controlled trial protocol to evaluate the therapeutic efficacy of lyophilised faecal microbiota capsules amended with next-generation beneficial bacteria in individuals with metabolic dysfunction-associated steatohepatitis | Synapse

⌘+K

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1PROMISE: a PROspective randomised double-blind parallel group placebo-controlled multicentre trial of faecal MIcrobiota tranSplantation to improve outcomEs in patients with cirrhosis over 24 months—study protocol for a clinical trialHuman Clinical Trial · 2026
2Lactobacillus rhamnosus Lysate for Metabolic Dysfunction-Associated Steatotic Liver Disease: A Randomized Controlled TrialRandomized Controlled Trial · 2026
3Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial2025 · 34 citations
4Effects of Multistrain Probiotic Supplementation on Hepatic Function and Anthropometric Parameters in Patients with Metabolic dysfunction-associated steatotic liver disease: A Double-Blind, Randomized Controlled Trial.RCT · 2026 · 1 citations
5Effect of Supplementation of a Butyrate-Based Formula in Individuals with Liver Steatosis and Metabolic Syndrome: A Randomized Double-Blind Placebo-Controlled Clinical Trial2024 · 44 citations

More from SHILAP Revista de lepidopterología

More from University of Amsterdam